SavedAdd your journal

Journals / Turkish Journal of Gastroenterology / 2015 / Cilt: 26 - Sayı: 3

Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C

Ebubekir ŞENATEŞ
Yaşar ÇOLAK
Atakan YEŞİL
İlyas TUNCER
Pages
283–283
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ŞENATEŞ, E., ÇOLAK, Y., YEŞİL, A., TUNCER, İ. (2015). Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C. Turkish Journal of Gastroenterology, Cilt: 26 - Sayı: 3, 283–283. https://ajindex.com/articles/410240

References (3)

  1. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB
  2. American Association for Study of Liver Diseases. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011
  3. [CrossRef] 2. PRODUCT MONOGRAPH PrINCIVEK® Telaprevir Tablets 375 mg Antiviral Agent Manufactured by: Vertex Pharmaceuticals Incorporated Distributed by: Vertex Pharmaceuticals (Canada) Incorporated 275 Armand-Frappier Boulevard Laval, Quebec H7V 4A7 Date of Revision: December 17, 2013 Submission Control (Web Access: http://pi.vrtx.com/ files/canadapm_telaprevir_en.pdf )